English

    Overview

  • Dr. Rajendra Pol is a senior consultant in haematology and Bone Marrow Transplantation at Manipal Hospitals, Baner, Pune, with over 20 years of overall medical experience and more than 8 years as a specialist in hematology and transplant medicine. He is widely respected for his expertise in managing complex blood disorders and performing high-risk transplants with precision and compassion.

  • Dr. Pol completed his MBBS (1999) and MD in Internal Medicine (2002) from Pune University. He pursued advanced training in the UK, earning his MRCP (2006) and FRCPath (Haematology, 2014) from the Royal College of Pathologists. He further specialised with a fellowship in Bone Marrow Transplantation under the British Society for Blood and Marrow Transplantation (BSBMT).

  • He has independently performed over 1,500 autologous and 500 allogeneic bone marrow transplants, along with 55+ CAR-T therapy procedures, making him one of the most experienced hematologists in this field in India. His clinical interests include leukemia, lymphoma, multiple myeloma, aplastic anemia, sickle cell anemia, and bone marrow failure syndromes.

  • Dr. Pol has actively contributed to several international research trials, including MoTD, AML-RIC, AUTO3, and ALL-RIC during his tenure in the UK. He is also a member of the British Society of Haematology and the Royal College of Pathologists (UK).

  • At Manipal Hospitals, Baner, Dr. Rajendra Pol is known for blending clinical excellence with a compassionate, patient-first approach, offering comprehensive, multidisciplinary care that helps patients and families navigate the most challenging hematological conditions with clarity and confidence.

  • Field of Expertise

  • Haematology
  • Fellowship & Membership

  • British Society of Heamatology UK.
  • Member of Royal College of Pathologists UK.
  • Languages Spoken

  • English
  • Hindi
  • Marathi
  • Gujrati
  • Talks & Publications

  • Bone marrow fibrosis is not a predictor of overall survival in patients with multiple myeloma. R Pol, S Paneesha, N Chachlani, H Freeman, P Roberts, G Pratt, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Dexamethasone, Ifosfamide, Carboplatin and Etoposide (DICarE) with/out Rituximab is an effective regimen for elderly patients with high-grade lymphoma and poor cardiac function. S Paneesha, C Connor, R Pol, N Evans, N Chachlani, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Bone Marrow Fibrosis is a Negative Predictor for Osteolytic Lesions in Patients with Myeloma. S Paneesha, Raj Pol, N Chachlani, Guy Pratt, Peter Rose and Anton Borg. ‘American Society of Haematology’ Dec 2006. ‘British Journal of Haematology 2007’.
  • Image: ‘All that glitters is not gold’ (Thrombocytosis as a manifestation of renal cell carcinoma). S Paneesha, R Pol. N Chachlani, M Hughes, K Chen, P Rose and A Borg. Bloodmed 2006.
  • http://www.bloodmed.com/education/case1.asp?id=2065. The use of a faecal management device in gastrointestinal graft-versus-host disease.
  • S. Liebersbach, A. Wood, N. Davis, R. Pol, R. Mazumdar, G. Cook, M. Gilleece (Leeds, UK), 36th Annual Meeting of the European Group for Blood and Marrow Transplantation, Vienna, Austria, March 2010.
  • Image - Daunorubicin-induced Hyperpigmentation, published in British Journal of Haematology in Aug 2010. Raj Pol, Andrew Wright, Anita Hill.
  • Image – A man with anaemia and a change in personality, Blood, March 2014. Raj Pol, Martin Howard.
  • A Single centre experience in severe Veno-Occlusive Disease and Early Treatment with Defibrotide. Raj R. Pol, Nigel Russell, Emma Das-Gupta, Lynne Watson, Lisa Rachael, Jenny Byrne. Bone Marrow Transplantation advance online publication, 25 April 2016; doi:10.1038/bmt.2016.99. Also EBMT oral presentation in 2016.
  • Effective Treatment of Steroid and Therapy-R.
  • World Thalassemia Day: Dr. Rajendra Pol, Haematologist at Manipal Hospital, Baner, Pune. Click Here
  • World Sickle Cell Day: All you need to know about Sickle cell - Dr Rajendra Pol. Click Here

    Fellowship & Membership

  • British Society of Heamatology UK.
  • Member of Royal College of Pathologists UK.
  • Overview

  • Dr. Rajendra Pol is a senior consultant in haematology and Bone Marrow Transplantation at Manipal Hospitals, Baner, Pune, with over 20 years of overall medical experience and more than 8 years as a specialist in hematology and transplant medicine. He is widely respected for his expertise in managing complex blood disorders and performing high-risk transplants with precision and compassion.

  • Dr. Pol completed his MBBS (1999) and MD in Internal Medicine (2002) from Pune University. He pursued advanced training in the UK, earning his MRCP (2006) and FRCPath (Haematology, 2014) from the Royal College of Pathologists. He further specialised with a fellowship in Bone Marrow Transplantation under the British Society for Blood and Marrow Transplantation (BSBMT).

  • He has independently performed over 1,500 autologous and 500 allogeneic bone marrow transplants, along with 55+ CAR-T therapy procedures, making him one of the most experienced hematologists in this field in India. His clinical interests include leukemia, lymphoma, multiple myeloma, aplastic anemia, sickle cell anemia, and bone marrow failure syndromes.

  • Dr. Pol has actively contributed to several international research trials, including MoTD, AML-RIC, AUTO3, and ALL-RIC during his tenure in the UK. He is also a member of the British Society of Haematology and the Royal College of Pathologists (UK).

  • At Manipal Hospitals, Baner, Dr. Rajendra Pol is known for blending clinical excellence with a compassionate, patient-first approach, offering comprehensive, multidisciplinary care that helps patients and families navigate the most challenging hematological conditions with clarity and confidence.

  • Field of Expertise

  • Haematology
  • Languages Spoken

  • English
  • Hindi
  • Marathi
  • Gujrati
  • Talks & Publications

  • Bone marrow fibrosis is not a predictor of overall survival in patients with multiple myeloma. R Pol, S Paneesha, N Chachlani, H Freeman, P Roberts, G Pratt, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Dexamethasone, Ifosfamide, Carboplatin and Etoposide (DICarE) with/out Rituximab is an effective regimen for elderly patients with high-grade lymphoma and poor cardiac function. S Paneesha, C Connor, R Pol, N Evans, N Chachlani, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Bone Marrow Fibrosis is a Negative Predictor for Osteolytic Lesions in Patients with Myeloma. S Paneesha, Raj Pol, N Chachlani, Guy Pratt, Peter Rose and Anton Borg. ‘American Society of Haematology’ Dec 2006. ‘British Journal of Haematology 2007’.
  • Image: ‘All that glitters is not gold’ (Thrombocytosis as a manifestation of renal cell carcinoma). S Paneesha, R Pol. N Chachlani, M Hughes, K Chen, P Rose and A Borg. Bloodmed 2006.
  • http://www.bloodmed.com/education/case1.asp?id=2065. The use of a faecal management device in gastrointestinal graft-versus-host disease.
  • S. Liebersbach, A. Wood, N. Davis, R. Pol, R. Mazumdar, G. Cook, M. Gilleece (Leeds, UK), 36th Annual Meeting of the European Group for Blood and Marrow Transplantation, Vienna, Austria, March 2010.
  • Image - Daunorubicin-induced Hyperpigmentation, published in British Journal of Haematology in Aug 2010. Raj Pol, Andrew Wright, Anita Hill.
  • Image – A man with anaemia and a change in personality, Blood, March 2014. Raj Pol, Martin Howard.
  • A Single centre experience in severe Veno-Occlusive Disease and Early Treatment with Defibrotide. Raj R. Pol, Nigel Russell, Emma Das-Gupta, Lynne Watson, Lisa Rachael, Jenny Byrne. Bone Marrow Transplantation advance online publication, 25 April 2016; doi:10.1038/bmt.2016.99. Also EBMT oral presentation in 2016.
  • Effective Treatment of Steroid and Therapy-R.
  • World Thalassemia Day: Dr. Rajendra Pol, Haematologist at Manipal Hospital, Baner, Pune. Click Here
  • World Sickle Cell Day: All you need to know about Sickle cell - Dr Rajendra Pol. Click Here

    Languages Spoken

  • English
  • Hindi
  • Marathi
  • Gujrati
  • Overview

  • Dr. Rajendra Pol is a senior consultant in haematology and Bone Marrow Transplantation at Manipal Hospitals, Baner, Pune, with over 20 years of overall medical experience and more than 8 years as a specialist in hematology and transplant medicine. He is widely respected for his expertise in managing complex blood disorders and performing high-risk transplants with precision and compassion.

  • Dr. Pol completed his MBBS (1999) and MD in Internal Medicine (2002) from Pune University. He pursued advanced training in the UK, earning his MRCP (2006) and FRCPath (Haematology, 2014) from the Royal College of Pathologists. He further specialised with a fellowship in Bone Marrow Transplantation under the British Society for Blood and Marrow Transplantation (BSBMT).

  • He has independently performed over 1,500 autologous and 500 allogeneic bone marrow transplants, along with 55+ CAR-T therapy procedures, making him one of the most experienced hematologists in this field in India. His clinical interests include leukemia, lymphoma, multiple myeloma, aplastic anemia, sickle cell anemia, and bone marrow failure syndromes.

  • Dr. Pol has actively contributed to several international research trials, including MoTD, AML-RIC, AUTO3, and ALL-RIC during his tenure in the UK. He is also a member of the British Society of Haematology and the Royal College of Pathologists (UK).

  • At Manipal Hospitals, Baner, Dr. Rajendra Pol is known for blending clinical excellence with a compassionate, patient-first approach, offering comprehensive, multidisciplinary care that helps patients and families navigate the most challenging hematological conditions with clarity and confidence.

  • Fellowship & Membership

  • British Society of Heamatology UK.
  • Member of Royal College of Pathologists UK.
  • Field of Expertise

  • Haematology
  • Talks & Publications

  • Bone marrow fibrosis is not a predictor of overall survival in patients with multiple myeloma. R Pol, S Paneesha, N Chachlani, H Freeman, P Roberts, G Pratt, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Dexamethasone, Ifosfamide, Carboplatin and Etoposide (DICarE) with/out Rituximab is an effective regimen for elderly patients with high-grade lymphoma and poor cardiac function. S Paneesha, C Connor, R Pol, N Evans, N Chachlani, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Bone Marrow Fibrosis is a Negative Predictor for Osteolytic Lesions in Patients with Myeloma. S Paneesha, Raj Pol, N Chachlani, Guy Pratt, Peter Rose and Anton Borg. ‘American Society of Haematology’ Dec 2006. ‘British Journal of Haematology 2007’.
  • Image: ‘All that glitters is not gold’ (Thrombocytosis as a manifestation of renal cell carcinoma). S Paneesha, R Pol. N Chachlani, M Hughes, K Chen, P Rose and A Borg. Bloodmed 2006.
  • http://www.bloodmed.com/education/case1.asp?id=2065. The use of a faecal management device in gastrointestinal graft-versus-host disease.
  • S. Liebersbach, A. Wood, N. Davis, R. Pol, R. Mazumdar, G. Cook, M. Gilleece (Leeds, UK), 36th Annual Meeting of the European Group for Blood and Marrow Transplantation, Vienna, Austria, March 2010.
  • Image - Daunorubicin-induced Hyperpigmentation, published in British Journal of Haematology in Aug 2010. Raj Pol, Andrew Wright, Anita Hill.
  • Image – A man with anaemia and a change in personality, Blood, March 2014. Raj Pol, Martin Howard.
  • A Single centre experience in severe Veno-Occlusive Disease and Early Treatment with Defibrotide. Raj R. Pol, Nigel Russell, Emma Das-Gupta, Lynne Watson, Lisa Rachael, Jenny Byrne. Bone Marrow Transplantation advance online publication, 25 April 2016; doi:10.1038/bmt.2016.99. Also EBMT oral presentation in 2016.
  • Effective Treatment of Steroid and Therapy-R.
  • World Thalassemia Day: Dr. Rajendra Pol, Haematologist at Manipal Hospital, Baner, Pune. Click Here
  • World Sickle Cell Day: All you need to know about Sickle cell - Dr Rajendra Pol. Click Here

    Field of Expertise

  • Haematology
  • Fellowship & Membership

  • British Society of Heamatology UK.
  • Member of Royal College of Pathologists UK.
  • Languages Spoken

  • English
  • Hindi
  • Marathi
  • Gujrati
  • Talks & Publications

  • Bone marrow fibrosis is not a predictor of overall survival in patients with multiple myeloma. R Pol, S Paneesha, N Chachlani, H Freeman, P Roberts, G Pratt, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Dexamethasone, Ifosfamide, Carboplatin and Etoposide (DICarE) with/out Rituximab is an effective regimen for elderly patients with high-grade lymphoma and poor cardiac function. S Paneesha, C Connor, R Pol, N Evans, N Chachlani, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Bone Marrow Fibrosis is a Negative Predictor for Osteolytic Lesions in Patients with Myeloma. S Paneesha, Raj Pol, N Chachlani, Guy Pratt, Peter Rose and Anton Borg. ‘American Society of Haematology’ Dec 2006. ‘British Journal of Haematology 2007’.
  • Image: ‘All that glitters is not gold’ (Thrombocytosis as a manifestation of renal cell carcinoma). S Paneesha, R Pol. N Chachlani, M Hughes, K Chen, P Rose and A Borg. Bloodmed 2006.
  • http://www.bloodmed.com/education/case1.asp?id=2065. The use of a faecal management device in gastrointestinal graft-versus-host disease.
  • S. Liebersbach, A. Wood, N. Davis, R. Pol, R. Mazumdar, G. Cook, M. Gilleece (Leeds, UK), 36th Annual Meeting of the European Group for Blood and Marrow Transplantation, Vienna, Austria, March 2010.
  • Image - Daunorubicin-induced Hyperpigmentation, published in British Journal of Haematology in Aug 2010. Raj Pol, Andrew Wright, Anita Hill.
  • Image – A man with anaemia and a change in personality, Blood, March 2014. Raj Pol, Martin Howard.
  • A Single centre experience in severe Veno-Occlusive Disease and Early Treatment with Defibrotide. Raj R. Pol, Nigel Russell, Emma Das-Gupta, Lynne Watson, Lisa Rachael, Jenny Byrne. Bone Marrow Transplantation advance online publication, 25 April 2016; doi:10.1038/bmt.2016.99. Also EBMT oral presentation in 2016.
  • Effective Treatment of Steroid and Therapy-R.
  • World Thalassemia Day: Dr. Rajendra Pol, Haematologist at Manipal Hospital, Baner, Pune. Click Here
  • World Sickle Cell Day: All you need to know about Sickle cell - Dr Rajendra Pol. Click Here
  • Overview

  • Dr. Rajendra Pol is a senior consultant in haematology and Bone Marrow Transplantation at Manipal Hospitals, Baner, Pune, with over 20 years of overall medical experience and more than 8 years as a specialist in hematology and transplant medicine. He is widely respected for his expertise in managing complex blood disorders and performing high-risk transplants with precision and compassion.

  • Dr. Pol completed his MBBS (1999) and MD in Internal Medicine (2002) from Pune University. He pursued advanced training in the UK, earning his MRCP (2006) and FRCPath (Haematology, 2014) from the Royal College of Pathologists. He further specialised with a fellowship in Bone Marrow Transplantation under the British Society for Blood and Marrow Transplantation (BSBMT).

  • He has independently performed over 1,500 autologous and 500 allogeneic bone marrow transplants, along with 55+ CAR-T therapy procedures, making him one of the most experienced hematologists in this field in India. His clinical interests include leukemia, lymphoma, multiple myeloma, aplastic anemia, sickle cell anemia, and bone marrow failure syndromes.

  • Dr. Pol has actively contributed to several international research trials, including MoTD, AML-RIC, AUTO3, and ALL-RIC during his tenure in the UK. He is also a member of the British Society of Haematology and the Royal College of Pathologists (UK).

  • At Manipal Hospitals, Baner, Dr. Rajendra Pol is known for blending clinical excellence with a compassionate, patient-first approach, offering comprehensive, multidisciplinary care that helps patients and families navigate the most challenging hematological conditions with clarity and confidence.

    Talks & Publications

  • Bone marrow fibrosis is not a predictor of overall survival in patients with multiple myeloma. R Pol, S Paneesha, N Chachlani, H Freeman, P Roberts, G Pratt, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Dexamethasone, Ifosfamide, Carboplatin and Etoposide (DICarE) with/out Rituximab is an effective regimen for elderly patients with high-grade lymphoma and poor cardiac function. S Paneesha, C Connor, R Pol, N Evans, N Chachlani, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Bone Marrow Fibrosis is a Negative Predictor for Osteolytic Lesions in Patients with Myeloma. S Paneesha, Raj Pol, N Chachlani, Guy Pratt, Peter Rose and Anton Borg. ‘American Society of Haematology’ Dec 2006. ‘British Journal of Haematology 2007’.
  • Image: ‘All that glitters is not gold’ (Thrombocytosis as a manifestation of renal cell carcinoma). S Paneesha, R Pol. N Chachlani, M Hughes, K Chen, P Rose and A Borg. Bloodmed 2006.
  • http://www.bloodmed.com/education/case1.asp?id=2065. The use of a faecal management device in gastrointestinal graft-versus-host disease.
  • S. Liebersbach, A. Wood, N. Davis, R. Pol, R. Mazumdar, G. Cook, M. Gilleece (Leeds, UK), 36th Annual Meeting of the European Group for Blood and Marrow Transplantation, Vienna, Austria, March 2010.
  • Image - Daunorubicin-induced Hyperpigmentation, published in British Journal of Haematology in Aug 2010. Raj Pol, Andrew Wright, Anita Hill.
  • Image – A man with anaemia and a change in personality, Blood, March 2014. Raj Pol, Martin Howard.
  • A Single centre experience in severe Veno-Occlusive Disease and Early Treatment with Defibrotide. Raj R. Pol, Nigel Russell, Emma Das-Gupta, Lynne Watson, Lisa Rachael, Jenny Byrne. Bone Marrow Transplantation advance online publication, 25 April 2016; doi:10.1038/bmt.2016.99. Also EBMT oral presentation in 2016.
  • Effective Treatment of Steroid and Therapy-R.
  • World Thalassemia Day: Dr. Rajendra Pol, Haematologist at Manipal Hospital, Baner, Pune. Click Here
  • World Sickle Cell Day: All you need to know about Sickle cell - Dr Rajendra Pol. Click Here
  • Overview

  • Dr. Rajendra Pol is a senior consultant in haematology and Bone Marrow Transplantation at Manipal Hospitals, Baner, Pune, with over 20 years of overall medical experience and more than 8 years as a specialist in hematology and transplant medicine. He is widely respected for his expertise in managing complex blood disorders and performing high-risk transplants with precision and compassion.

  • Dr. Pol completed his MBBS (1999) and MD in Internal Medicine (2002) from Pune University. He pursued advanced training in the UK, earning his MRCP (2006) and FRCPath (Haematology, 2014) from the Royal College of Pathologists. He further specialised with a fellowship in Bone Marrow Transplantation under the British Society for Blood and Marrow Transplantation (BSBMT).

  • He has independently performed over 1,500 autologous and 500 allogeneic bone marrow transplants, along with 55+ CAR-T therapy procedures, making him one of the most experienced hematologists in this field in India. His clinical interests include leukemia, lymphoma, multiple myeloma, aplastic anemia, sickle cell anemia, and bone marrow failure syndromes.

  • Dr. Pol has actively contributed to several international research trials, including MoTD, AML-RIC, AUTO3, and ALL-RIC during his tenure in the UK. He is also a member of the British Society of Haematology and the Royal College of Pathologists (UK).

  • At Manipal Hospitals, Baner, Dr. Rajendra Pol is known for blending clinical excellence with a compassionate, patient-first approach, offering comprehensive, multidisciplinary care that helps patients and families navigate the most challenging hematological conditions with clarity and confidence.

  • Fellowship & Membership

  • British Society of Heamatology UK.
  • Member of Royal College of Pathologists UK.
  • Field of Expertise

  • Haematology
  • Languages Spoken

  • English
  • Hindi
  • Marathi
  • Gujrati

Doctor Videos

Blogs

Google Reviews

11 Google reviews

FAQ's

Patients visit Dr. Rajendra Pol, a leading Consultant - Heamatology at Manipal Hospitals Baner - Pune, for expert care and advanced treatments. Known for accurate diagnoses and patient centric care, Dr. Rajendra Pol is a trusted choice for exceptional medical support.